A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis

Clinical trial NCT05382715 · TERMINATED

Trial details

NCT number: NCT05382715
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Study type: OBSERVATIONAL

Colitis, Ulcerative

Start date: 2022-05-30
Primary completion: 2025-05-31
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.